Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/218526
Title: Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression
Author: Molina, Òscar
Ortega-Sabater, Carmen
Thampi, Namitha
Fernandez Fuentes, Narcís
Guerrero-Murillo, Mercedes
Martínez-Moreno, Alba
Vinyoles, Meritxell
Velasco-Hernandez, Talia
Bueno, Clara
Trincado, Juan L..
Granada, Isabel
Campos, Diana
Giménez, Carles
Boer, Judith M.
Den Boer, Monique L.
Fernández Calvo, Gabriel
Camós Guijosa, Mireia
Fuster, José Luis
Velasco, Pablo
Ballerini, Paola
Locatelli, Franco
Mullighan, Charles G.
Spierings, Diana C.J.
Foijer, Floris
Pérez-García, Víctor M.
Menéndez, Pablo
Keywords: Animals
Leucèmia
Anomalies cromosòmiques
Infants
Animals
Leukemia
Chromosome abnormalities
Children
Issue Date: 15-Nov-2023
Publisher: EMBO Press
Abstract: Chromosomal instability (CIN) lies at the core of cancer development leading to aneuploidy, chromosomal copy-number heterogeneity (chr-CNH) and ultimately, unfavorable clinical outcomes. Despite its ubiquity in cancer, the presence of CIN in childhood B-cell acute lymphoblastic leukemia (cB-ALL), the most frequent pediatric cancer showing high frequencies of aneuploidy, remains unknown. Here, we elucidate the presence of CIN in aneuploid cB-ALL subtypes using single-cell whole-genome sequencing of primary cB-ALL samples and by generating and functionally characterizing patient-derived xenograft models (cB-ALL-PDX). We report higher rates of CIN across aneuploid than in euploid cB-ALL that strongly correlate with intraclonal chr-CNH and overall survival in mice. This association was further supported by in silico mathematical modeling. Moreover, mass-spectrometry analyses of cB-ALL-PDX revealed a "CIN signature" enriched in mitotic-spindle regulatory pathways, which was confirmed by RNA-sequencing of a large cohort of cB-ALL samples. The link between the presence of CIN in aneuploid cB-ALL and disease progression opens new possibilities for patient stratification and offers a promising new avenue as a therapeutic target in cB-ALL treatment.
Note: Reproducció del document publicat a: https://doi.org/10.1038/s44321-023-00006-w
It is part of: EMBO Molecular Medicine, 2023, vol. 16, p. 64-92
URI: https://hdl.handle.net/2445/218526
Related resource: https://doi.org/10.1038/s44321-023-00006-w
ISSN: 1757-4676
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)

Files in This Item:
File Description SizeFormat 
873636.pdf5.46 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons